Fingerprint
Dive into the research topics of 'SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer
Ming Yang, Wanling Xie, Elahe Mostaghel, Mari Nakabayashi, Lillian Werner, Tong Sun, Mark Pomerantz, Matthew Freedman, Robert Ross, Meredith Regan, Nima Sharifi, William Douglas Figg, Steven Balk, Myles Brown, Mary Ellen Taplin, William K. Oh, Gwo Shu Mary Lee, Philip W. Kantoff
Research output: Contribution to journal › Article › peer-review
146
Scopus
citations